Menopause Hormone Therapy Heart Risk Study
Analysis based on 9 articles · First reported Sep 08, 2026 · Last updated Sep 11, 2026
The study may modestly support demand for menopause hormone therapy products by reinforcing a more favorable cardiovascular safety narrative for early initiation, a positive for makers of estrogen therapies. However, the authors' explicit caution against using hormone therapy for heart prevention and the observational design limit any near-term change to prescribing guidelines or revenue forecasts.
A new observational analysis published in JAMA Internal Medicine on Sept. 8, 2026, reports that women with vasomotor symptoms (hot flashes and night sweats) who started menopause hormone therapy during perimenopause or early postmenopause had a 22% lower risk of cardiovascular events than similar women who did not start treatment. The study was led by researchers at Virginia Commonwealth University and the University of Pittsburgh, using roughly 20 years of data (1997-2017) from more than 2,700 participants in the Study of Women's Health Across the Nation (SWAN), funded by the United States — National Institutes of Health. The apparent benefit was strongest among women who began therapy within 10 years of menopause onset (about 27% lower risk) and among Black women (about 49% lower risk). No clear benefit was seen for women starting more than 10 years after menopause or for White women and other racial and ethnic groups. The authors cautioned that the study was not a randomized trial and that findings should not be used to prescribe hormone therapy for cardiovascular prevention. The results arrive as the United States — Food and Drug Administration has removed broad boxed warnings from hormone therapy products, reflecting evolving evidence. Lead author Ziyuan Wang is now at Eli Lilly and Company, and independent expert Stephanie Luo of Northwell Health commented on the findings, emphasizing individualized care.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard